GALEOTTI, FABIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.857
AS - Asia 3.950
EU - Europa 3.520
SA - Sud America 561
AF - Africa 134
OC - Oceania 47
Continente sconosciuto - Info sul continente non disponibili 8
Totale 15.077
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.722
SG - Singapore 1.332
GB - Regno Unito 1.315
CN - Cina 796
IT - Italia 636
HK - Hong Kong 457
BR - Brasile 397
VN - Vietnam 363
DE - Germania 270
SE - Svezia 247
TR - Turchia 233
FI - Finlandia 184
FR - Francia 173
IN - India 128
RU - Federazione Russa 122
UA - Ucraina 121
KR - Corea 102
ID - Indonesia 99
AR - Argentina 71
BG - Bulgaria 69
JP - Giappone 64
CA - Canada 58
PL - Polonia 48
MX - Messico 47
PK - Pakistan 46
GR - Grecia 40
TH - Thailandia 40
BD - Bangladesh 35
AU - Australia 34
MY - Malesia 34
ES - Italia 33
CH - Svizzera 31
IR - Iran 30
NL - Olanda 30
CL - Cile 27
LT - Lituania 27
IQ - Iraq 26
RS - Serbia 26
ZA - Sudafrica 25
TN - Tunisia 24
EG - Egitto 22
DZ - Algeria 21
AT - Austria 19
SA - Arabia Saudita 19
CO - Colombia 18
AE - Emirati Arabi Uniti 17
BE - Belgio 17
PT - Portogallo 17
UZ - Uzbekistan 17
MA - Marocco 16
RO - Romania 16
DK - Danimarca 15
PH - Filippine 15
QA - Qatar 15
NZ - Nuova Zelanda 13
IE - Irlanda 12
VE - Venezuela 12
LB - Libano 11
SI - Slovenia 11
TW - Taiwan 11
EC - Ecuador 10
IL - Israele 10
PE - Perù 9
HR - Croazia 8
AZ - Azerbaigian 7
BO - Bolivia 7
CR - Costa Rica 7
ET - Etiopia 7
NP - Nepal 7
CZ - Repubblica Ceca 6
EU - Europa 6
JO - Giordania 6
KE - Kenya 5
MO - Macao, regione amministrativa speciale della Cina 5
UY - Uruguay 5
CU - Cuba 4
DO - Repubblica Dominicana 4
HN - Honduras 4
KZ - Kazakistan 4
NG - Nigeria 4
NO - Norvegia 4
PY - Paraguay 4
UG - Uganda 4
AL - Albania 3
AM - Armenia 3
BY - Bielorussia 3
MK - Macedonia 3
OM - Oman 3
SK - Slovacchia (Repubblica Slovacca) 3
SM - San Marino 3
BB - Barbados 2
BH - Bahrain 2
CI - Costa d'Avorio 2
GE - Georgia 2
GT - Guatemala 2
HU - Ungheria 2
KH - Cambogia 2
KW - Kuwait 2
LU - Lussemburgo 2
SY - Repubblica araba siriana 2
Totale 15.054
Salva come PNG Salva come JPEG
Città #
Singapore 976
Southend 944
Santa Clara 723
Fairfield 716
Ashburn 679
Woodbridge 466
Chandler 458
Hong Kong 443
Houston 314
Seattle 277
San Jose 258
Cambridge 235
Dearborn 222
Wilmington 221
Beijing 217
Nyköping 210
Council Bluffs 169
London 164
Jacksonville 155
Ann Arbor 151
Modena 141
Helsinki 132
Ho Chi Minh City 107
The Dalles 100
Hefei 86
New York 86
Hanoi 81
Izmir 81
Los Angeles 65
Redwood City 61
Sofia 61
Jakarta 59
Princeton 55
Eugene 54
Seoul 54
Lauterbourg 45
San Diego 42
Leipzig 41
Shanghai 41
Dong Ket 40
Istanbul 38
Tokyo 35
São Paulo 34
Moscow 32
Milan 31
Buffalo 30
Munich 30
Hillsboro 26
Bangkok 24
Chicago 23
Columbus 23
Belgrade 22
Ankara 21
Nuremberg 20
Dallas 19
Orem 19
Rome 19
Chennai 18
Jinan 18
Mexico City 18
Turku 18
Belo Horizonte 17
Falkenstein 17
Redondo Beach 17
Atlanta 16
Bologna 15
Doha 15
Frankfurt am Main 15
Guangzhou 15
Haiphong 15
Tashkent 15
Brussels 14
Florence 14
Rio de Janeiro 14
Basingstoke 13
Delhi 13
Madrid 13
Manchester 13
Paris 13
Parma 13
Amsterdam 12
Curitiba 12
Falls Church 12
Kunming 12
San Giuliano Milanese 12
Stockholm 12
Zhengzhou 12
Athens 11
Boardman 11
Lahore 11
Perugia 11
San Francisco 11
Sydney 11
Baghdad 10
Erzurum 10
Karachi 10
Montreal 10
Ottawa 10
Poznan 10
Ribeirão Preto 10
Totale 10.445
Salva come PNG Salva come JPEG
Nome #
ACTIVITY STUDIES OF CHARACTERIZED, STANDARDIZED AND HIGHLY PURIFIED PROPOLIS EXTRACT 696
Recent advances in analytical approaches for the standardization and quality of polyphenols of propolis 614
Chemical Composition and Antioxidant Activity of Propolis Prepared in Different Forms and in Different Solvents Useful for Finished Products 499
MOLECULAR COMPOSITION OF ACTIVE CHIOS MASTIC GUM COMPOUNDS, TERPENES, FOR USE IN COSMETIC, NUTRACEUTICAL, MEDICAL DEVICES AND PHARMACEUTICAL APPLICATIONS. 477
Differences among Three Branded Formulations of Hyaluronic Acid: Data from Environmental Scanning Electron Microscope Profile, Rheology Behavior and Biological Activity 402
Purification and structural elucidation of chondroitin sulfate/dermatan sulfate from Atlantic bluefin tuna (Thunnus thynnus) skins and their anticoagulant and ACE inhibitory activities 342
Chondroitin sulfate/dermatan sulfate from corb (Sciaena umbra) skin: Purification, structural analysis and anticoagulant effect 341
Analytical Methods for Assessing Chondroitin Sulfate in Human Plasma. 329
Mental retardation in mucopolysaccharidoses correlates with high molecular weight urinary heparan sulphate derived glucosamine. 322
Isolation, Purification and Structural Characterestics of Chondroitin Sulfate from Smooth hound Cartilage: In vitro Anticoagulant and Antiproliferative Properties 319
Capillary electrophoresis separation of human milk neutral and acidic oligosaccharides derivatized with 2-aminoacridone. 315
Biological effects and potential mechanisms of action of Pistacia lentiscus Chios mastic extract in Caco-2 cell model 308
Comparative analysis of fatty acid profile in three eutardigrade species 308
Analysis of glycosaminoglycan-derived, pre-column 2-aminoacridone-labeled disaccharides using liquid chromatography-fluorescence and -mass spectrometric detection. 298
Purification, Structural Characterization and Antiproliferative Properties of Chondroitin Sulfate/Dermatan Sulfate from Tunisian Fish Skins 295
Purification, compositional analysis, and anticoagulant capacity of chondroitin sulfate/dermatan sulfate from bone of corb (Sciaena umbra). 289
Recent advances on separation and characterization of human milk oligosaccharides. 288
Multi dynamic extraction: An innovative method to obtain a standardized chemically and biologically reproducible polyphenol extract from poplar-type propolis to be used for its anti-infective properties 280
Isolation and structural characterization of chondroitin sulfate from bony fishes 279
Characterization of Oversulfated Chondroitin Sulfate Rich in 4,6-O-disulfated Disaccharides in Breast Cyst Fluids Collected from Human Breast Gross Cysts. 278
Metabolic fate of milk glycosaminoglycans in breastfed and formula fed newborns. 268
Selective treatment to reduce contamination of propolis by polycyclic aromatic hydrocarbons (PAHs) still preserving its active polyphenol component and antioxidant activity 267
Recent advances in capillary electrophoresis separation of monosaccharides, oligosaccharides and polysaccharides 263
Mild mental retardation and low levels of urinary heparan sulfate in a patient with the attenuated phenotype of Mucopolysaccharidosis type IIIA. 253
Plasmatic kinetics of dermatan sulfate during enzyme replacement therapy with iduronate-2-sulfatase in a mucopolysaccharidosis II Patient 253
Glycosaminoglycan levels and structure in a mucopolysaccharidosis IIIA mice and the effect of a highly secreted sulfamidase engineered to cross the blood-brain barrier 251
Composition and structure of glycosaminoglycans in DBS from 2-3-day-old newborns for the diagnosis of mucopolysaccharidosis 250
Human milk glycosaminoglycans: the state of the art and future perspectives 248
Plasmatic and urinary glycosaminoglycan profile in a patient affected by multiple sulfatase deficiency 248
Novel reverse-phase ion pair-high performance liquid chromatography separation of heparin, heparan sulfate and Low molecular weight-heparins disaccharides and oligosaccharides. 247
Studies on European eel skin sulfated glycosaminoglycans: Recovery, structural characterization and anticoagulant activity 242
High quality Green (Brazilian) propolis extracts characterized for active biomolecules exert epigenetic effects able to have a positive influence on cell oxidative stress 240
Total and single species of uronic acid-bearing glycosaminoglycans in urine of newborns of 2-3 days of age for early diagnosis application 238
PURIFICATION OF PROPOLIS FROM POLYCYCLIC AROMATIC HYDROCARBONS AND PRESERVATION OF ACTIVE POLYPHENOL COMPONENT. 236
Plasma glycosaminoglycans as diagnostic and prognostic biomarkers in surgically treated renal cell carcinoma 234
Glycosaminoglycan profiling as a novel pan-cancer minimally invasive systems biomarker. 234
Oral bioavailability and pharmacokinetic of non-animal chondroitin sulfate and its constituents in healthy male volunteers 229
Breast Cyst Fluid Heparan Sulfate is Distinctively N-sulfated Depending on Apocrine or Flattened Type 228
Plasmatic dermatan sulfate and chondroitin sulfate determination in mucopolysaccharidoses 227
Human milk glycosaminoglycans. Handbook on dietary and nutritional aspects of human breast milk 224
Mucopolysaccharidosis type II: preliminary data on glycosaminoglycan levels and structure in mice at baseline and after 6 weeks treatment with ERT 222
Water Soluble Ppropolis (Greit120) and Human Interferon – α (HuIFN-AlfaN3) shows Anti – Influenza virus activity in vitro 218
Structural definition of terrestrial chondroitin sulfate of various origin and repeatability of the production process 210
Oligosaccharide mapping of heparinase I-treated heparins by hydrophilic interaction liquid chromatography separation and online fluorescence detection and electrospray ionization-mass spectrometry characterization. 206
Plasma glycosaminoglycan scores in early stage renal cell carcinoma 201
Selective removal of keratan sulfate in chondroitin sulfate samples by sequential precipitation with ethanol 199
Chemical composition and antioxidant activity of propolis prepared in different forms and in different solvents useful for finished products 191
High-throughput determination of urinary hexosamines in newborns of 2-3 days of age: application for the early diagnosis of mucopolysaccharidoses 190
Determination of total and single species of all uronic acid-bearing glycosaminoglycans in urine of newborns of 2-3 days of age for a possible early diagnosis of mucopolysaccharidoses 184
CHARACTERIZED PROPOLIS EXTRACTS, OBTAINED WITH STANDARDIZED EXTRACTION METHOD, SHOWN SIMILAR CHEMICAL PROFILE (HPLC-ESI-MSN) AND IN VITRO ANTIBACTERIAL, ANTIOXIDANT AND ANTI-INFLAMMATORY ACTIVITY TROUGH EVALUATION OF EXPRESSION OF miRNAS, mRNAS AND PROTEINS 175
Approccio globale alle mucopolisaccaridosi: creazione piattaforma web-based 173
Rigon L, Maccari F, Salvalaio M, Legnini E, D’Avanzo F, Galeotti F, Mantovani V, Gabrielli O, Marin O, Scarpa M, Volpi N, Tomanin R. Glycosaminoglycan profile in the Mucopolysaccharidosis type II mouse model at baseline and after 6 weeks treatment with ERT 170
Variazioni del dermatan solfato plasmatico durante la terapia enzimatica sostitutiva con iduronato-2-solfatasi in un paziente affetto da mucopolisaccaridosi II 158
Propolis: innovation and new applications based on its fine structural composition 149
Human milk glycosaminoglycan composition from women of different countries: a pilot study 142
Noninvasive detection of any-stage cancer using free glycosaminoglycans 107
Urinary Free Glycosaminoglycans Identify Adults at High Risk of Developing Early-stage High-grade Bladder Cancer 107
Mucopolisaccaridosi: approcci analitici alla diagnosi asintomatica. 60
Totale 15.221
Salva come PNG Salva come JPEG
Categoria #
all - tutte 51.142
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.142
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021233 0 0 0 0 0 0 0 0 0 0 127 106
2021/20221.064 52 120 70 53 32 55 46 44 169 106 171 146
2022/20231.368 128 147 103 147 113 192 25 179 152 24 67 91
2023/20241.163 49 67 44 178 237 102 115 136 27 41 63 104
2024/20252.689 100 76 56 184 541 397 183 198 299 112 212 331
2025/20263.993 174 96 299 416 767 303 633 286 501 508 10 0
Totale 15.221